Pharma Journalist - Page 117 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

FDA Accepts BLA for Odronextamab in Treating Relapsed/Refractory Follicular Lymphoma

Lilly to Exceed $50 Billion in U.S. Manufacturing Investment, Doubling Since 2020

Sarclisa Approved in Japan for Newly Diagnosed Multiple Myeloma Patients

RedHill Licenses RHB-102 to Hyloris for Global Commercialization, Potentially Worth $60M

Summit Therapeutics Partners with Pfizer to Trial Ivonescimab with ADCs

Mirum’s CTEXLI Tablets FDA-Approved for Cerebrotendinous Xanthomatosis

FDA Accepts BMS’ SBLAs for Opdivo + Yervoy in MSI-High, MMR-D Cancer

EMA Validates Gilead’s Application for Twice-Yearly Lenacapavir as HIV Prevention

Teva and Alvotech Launch SELARSDI Injection in the U.S.

Boehringer’s Zongertinib Gets U.S. FDA Priority Review for HER2-Mutant Advanced NSCLC